{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T17:44:16Z","timestamp":1740159856679,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T00:00:00Z","timestamp":1670457600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Drug Metab Pharmacokinet"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s13318-022-00809-1","type":"journal-article","created":{"date-parts":[[2022,12,8]],"date-time":"2022-12-08T03:02:15Z","timestamp":1670468535000},"page":"101-114","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Population Pharmacokinetic\u2013Pharmacodynamic Modeling and Probability of Target Attainment Analysis of Rocuronium and Sugammadex in Children Undergoing Surgery"],"prefix":"10.1007","volume":"48","clinical-trial-number":[{"clinical-trial-number":"nct04851574","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4215-8730","authenticated-orcid":false,"given":"Ma\u0142gorzata","family":"Grze\u015bkowiak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7272-5738","authenticated-orcid":false,"given":"Agnieszka","family":"Bienert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2878-3161","authenticated-orcid":false,"given":"Pawe\u0142","family":"Wiczling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7219-7899","authenticated-orcid":false,"given":"Miros\u0142aw","family":"Malec","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8213-6021","authenticated-orcid":false,"given":"Joanna","family":"Grzelak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5444-5150","authenticated-orcid":false,"given":"Konrad","family":"Jarosz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2270-4386","authenticated-orcid":false,"given":"Justyna","family":"Ber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3382-8504","authenticated-orcid":false,"given":"Micha\u0142","family":"Ksi\u0105\u017ckiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8116-4028","authenticated-orcid":false,"given":"Jowita","family":"Rosada-Kurasi\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9938-6729","authenticated-orcid":false,"given":"Edmund","family":"Grze\u015bkowiak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4950-2346","authenticated-orcid":false,"given":"Alicja","family":"Bartkowska-\u015aniatkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,8]]},"reference":[{"issue":"19","key":"809_CR1","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.2174\/1381612825666190704101145","volume":"25","author":"J Hawkins","year":"2019","unstructured":"Hawkins J, Khanna S, Argalious M. Sugammadex for reversal of neuromuscular blockade: uses and limitations. Curr Pharm Des. 2019;25(19):2140\u20138.","journal-title":"Curr Pharm Des"},{"issue":"10","key":"809_CR2","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1080\/14740338.2019.1649393","volume":"18","author":"G Honing","year":"2019","unstructured":"Honing G, Martini CH, Bom A, van Velzen M, Niesters M, Aarts L, Dahan A, Boon M. Safety of sugammadex for reversal of neuromuscular block. Expert Opin Drug Saf. 2019;18(10):883\u201391.","journal-title":"Expert Opin Drug Saf"},{"issue":"4","key":"809_CR3","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1097\/00000542-200604000-00009","volume":"104","author":"IF Sorgenfrei","year":"2006","unstructured":"Sorgenfrei IF, Norrild K, Larsen PB, Stensballe J, Ostergaard D, Prins ME, Viby-Mogensen J. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology. 2006;104(4):667\u201374.","journal-title":"Anesthesiology"},{"issue":"1","key":"809_CR4","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1093\/bja\/aei314","volume":"96","author":"M Shields","year":"2006","unstructured":"Shields M, Giovanelli M, Mirakhur RK, Moppett I, Adams J, Hermens Y. Org 25969 (sugammadex), a selective relaxant binding agent for antagonism of prolonged rocuronium-induced neuromuscular block. Br J Anaesth. 2006;96(1):36\u201343.","journal-title":"Br J Anaesth"},{"issue":"2","key":"809_CR5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/00000542-200702000-00016","volume":"106","author":"K Suy","year":"2007","unstructured":"Suy K, Morias K, Cammu G, Hans P, van Duijnhoven WG, Heeringa M, Demeyer I. Effective reversal of moderate rocuronium- or vecuronium-induced neuromuscular block with sugammadex, a selective relaxant binding agent. Anesthesiology. 2007;106(2):283\u20138.","journal-title":"Anesthesiology"},{"issue":"3","key":"809_CR6","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1213\/01.ane.0000260135.46070.c3","volume":"104","author":"SB Groudine","year":"2007","unstructured":"Groudine SB, Soto R, Lien C, Drover D, Roberts K. A randomized, dose-finding, phase II study of the selective relaxantbinding drug, sugammadex, capable of safely reversing profound rocuronium-induced neuromuscular block. Anesth Analg. 2007;104(3):555\u201362.","journal-title":"Anesth Analg"},{"issue":"2","key":"809_CR7","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1097\/ALN.0b013e318194caaa","volume":"110","author":"B Plaud","year":"2009","unstructured":"Plaud B, Meretoja O, Hofmockel R, Raft J, Stoddart PA, van Kuijk JHM, Hermens Y, Mirakhur RK. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Anesthesiology. 2009;110(2):284\u201394.","journal-title":"Anesthesiology"},{"issue":"5","key":"809_CR8","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1097\/01.anes.0000265152.78943.74","volume":"106","author":"HJ Sparr","year":"2007","unstructured":"Sparr HJ, Vermeyen KM, Beaufort AM, Rietbergen H, Proost JH, Saldien V, Velik-Salchner C, Wierda JM. Early reversal of profound rocuronium-induced neuromuscular block by sugammadex in arandomized multicenter study: efficacy, safety, and pharmacokinetics. Anesthesiology. 2007;106(5):935\u201343.","journal-title":"Anesthesiology"},{"issue":"4","key":"809_CR9","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1213\/ANE.0000000000004207","volume":"129","author":"RS Gaver","year":"2019","unstructured":"Gaver RS, Brenn BR, Gartley A, Donahue BS. Retrospective analysis of the safety and efficacy of sugammadex versus neostigmine for the reversal of neuromuscular blockade in children. Anesth Analg. 2019;129(4):1124\u20139.","journal-title":"Anesth Analg"},{"issue":"4","key":"809_CR10","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/aas.12868","volume":"61","author":"AS Ammar","year":"2017","unstructured":"Ammar AS, Mahmoud KM, Kasemy ZA. A comparison of sugammadex and neostigmine for reversal of rocuronium-induced neuromuscular blockade in children. Acta Anaesthesiol Scand. 2017;61(4):374\u201380.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"10","key":"809_CR11","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1007\/s40265-016-0604-1","volume":"76","author":"GM Keating","year":"2016","unstructured":"Keating GM. Sugammadex: a review of neuromuscular blockade reversal. Drugs. 2016;76(10):1041\u201352.","journal-title":"Drugs"},{"issue":"1","key":"809_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12871-018-0605-6","volume":"18","author":"HD de Boer","year":"2018","unstructured":"de Boer HD, Carlos RV, Brull SJ. Is lower-dose sugammadex a cost-saving strategy for reversal of deep neuromuscular block? Facts and fiction. BMC Anesthesiol. 2018;18(1):159.","journal-title":"BMC Anesthesiol"},{"issue":"Suppl 1","key":"809_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00228-009-0782-9","volume":"67 Suppl 1","author":"RFW De Cock","year":"2011","unstructured":"De Cock RFW, Piana C, Krekels EHJ, Danhof M, Allegaert K, Knibbe CAJ. The role of population PK\u2013PD modelling in paediatric clinical research. Eur J Clin Pharmacol. 2011;67 Suppl 1(Suppl 1):5\u201316.","journal-title":"Eur J Clin Pharmacol"},{"issue":"1","key":"809_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/ALN.0b013e318190bc32","volume":"110","author":"BA Ploeger","year":"2009","unstructured":"Ploeger BA, Smeets J, Strougo A, Drenth HJ, Ruigt G, Houwing N, Danhof M. Pharmacokinetic\u2013pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex. Anesthesiology. 2009;110(1):95\u2013105.","journal-title":"Anesthesiology"},{"issue":"2","key":"809_CR15","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1097\/ALN.0b013e3182065c36","volume":"114","author":"DL McDonagh","year":"2011","unstructured":"McDonagh DL, Benedict PE, Kovac AL, Drover DR, Brister NW, Morte JB, Monk TG. Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients. Anesthesiology. 2011;114(2):318\u201329.","journal-title":"Anesthesiology"},{"issue":"3","key":"809_CR16","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1111\/j.1365-2125.2011.04000.x","volume":"72","author":"HJ Kleijn","year":"2011","unstructured":"Kleijn HJ, Zollinger DP, van den Heuvel MW, Kerbusch T. Population pharmacokinetic\u2013pharmacodynamic analysisfor sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade. Br J Clin Pharmacol. 2011;72(3):415\u201333.","journal-title":"Br J Clin Pharmacol"},{"issue":"9","key":"809_CR17","first-page":"746","volume":"55","author":"KC Min","year":"2017","unstructured":"Min KC, Lasseter KC, Marbury TC, Wrishko RE, Hanley WD, Wolford DG, de Haes JU, Reitmann C, Gutstein DE. Pharmacokinetics of sugammadex in subjects with moderate and severe renal impairment. Int J Clin Pharmacol Ther. 2017;55(9):746\u201352.","journal-title":"Int J Clin Pharmacol Ther"},{"issue":"4","key":"809_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.diagmicrobio.2020.115292","volume":"99","author":"A Cristinacce","year":"2021","unstructured":"Cristinacce A, Wright JG, Macpherson M, Iaconis J, Das S. Comparing probability of target attainment against Staphylococcus aureus for ceftaroline fosamil, vancomycin, daptomycin, linezolid, and ceftriaxone in complicated skin and soft tissue infection using pharmacokinetic\/pharmacodynamic models. Diagn Microbiol Infect Di. 2021;99(4): 115292.","journal-title":"Diagn Microbiol Infect Di"},{"issue":"5","key":"809_CR19","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.pharep.2014.04.012","volume":"66","author":"A Bartkowska-\u015aniatkowska","year":"2014","unstructured":"Bartkowska-\u015aniatkowska A, Bienert A, Wiczling P, Owczarek M, Rosada-Kurasi\u0144ska J, Grze\u015bkowiak M, Matysiak J, Kokot ZJ, Kaliszan R, Grze\u015bkowiak E. Pharmacokinetics and pharmacodynamics of propofol in children undergoing different types of surgeries. Pharmacol Rep. 2014;66(5):821\u20139.","journal-title":"Pharmacol Rep"},{"key":"809_CR20","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1111\/anae.15501","volume":"76","author":"AA Klein","year":"2021","unstructured":"Klein AA, Meek T, Allcock E, Cook TM, Mincher N, Morris C, Nimmo AF, Pandit JJ, Pawa A, Rodney G, Sheraton T, Young P. Recommendations for standards of monitoring during anaesthesia and recovery 2021: guideline from the Association of Anaesthetists. Anaesthesia. 2021;76:1212\u201323.","journal-title":"Anaesthesia"},{"key":"809_CR21","unstructured":"United States Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Veterinary Medicine (CVM) 2018. Bioanalytical method validation. Guidance for industry. https:\/\/www.fda.gov\/downloads\/Drugs\/Guidance\/ucm070107.pdf. Access 15 Feb 2020."},{"issue":"5","key":"809_CR22","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10928-020-09695-z","volume":"47","author":"AHXPC Kwong","year":"2020","unstructured":"Kwong AHXPC, Calvier EM, Fabre D, Gattacceca F, Khier S. Prior information for population pharmacokinetic and pharmacokinetic\/pharmacodynamic analysis: overview and guidance with a focus on the NONMEM PRIOR subroutine. J Pharmacokinet Pharmacodyn. 2020;47(5):431\u201346.","journal-title":"J Pharmacokinet Pharmacodyn"},{"key":"809_CR23","unstructured":"https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bridion-epar-product-information_en.pdf. Accessed 13 Jan 2022."},{"issue":"7","key":"809_CR24","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1111\/pan.13171","volume":"27","author":"JD Tobias","year":"2017","unstructured":"Tobias JD. Current evidence for the use of sugammadex in children. Pediatr Anesth. 2017;27(7):781.","journal-title":"Pediatr Anesth"},{"issue":"3","key":"809_CR25","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1097\/00000539-200203000-00022","volume":"94","author":"M Paul","year":"2002","unstructured":"Paul M, Kindler CH, Fokt RM, Dresser MJ, Dipp NC, Yost CS. The potency of new muscle relaxants on recombinant muscle-type acetylcholine receptors. Anesth Analg. 2002;94(3):597\u2013603.","journal-title":"Anesth Analg"},{"issue":"5","key":"809_CR26","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/bja\/aeq270","volume":"105","author":"D Chambers","year":"2010","unstructured":"Chambers D, Paulden M, Paton F, Heirs M, Duffy S, Hunter JM, Sculpher M, Woolacott N. Sugammadex for reversal of neuromuscular block after rapid sequence intubation: a systematic review and economic assessment. Br J Anaesth. 2010;105(5):568\u201375.","journal-title":"Br J Anaesth"},{"key":"809_CR27","first-page":"57","volume":"8","author":"SJ Schaller","year":"2013","unstructured":"Schaller SJ, Fink H. Sugammadex as a reversal agent for neuromuscular block: an evidence-based review. Core Evid. 2013;8:57\u201367.","journal-title":"Core Evid."},{"issue":"5","key":"809_CR28","doi-asserted-by":"publisher","first-page":"336","DOI":"10.5603\/AIT.2017.0079","volume":"49","author":"W Walas","year":"2017","unstructured":"Walas W, Aleksandrowicz D, Borszewska-Kornacka M, Gaszy\u0144ski T, Helwich E, Migda\u0142 M, Piotrowski A, Siejka G, Szczapa T, Bartkowska-\u015aniatkowska A. Unanticipated difficult airway management in children\u2014the consensus statement of the Paediatric Anaesthesiology and Intensive Care Section and the Airway Management Section of the Polish Society of Anaesthesiology and intensive Therapy and the Polish So. Anaesthesiol Intensive Ther. 2017;49(5):336\u201349.","journal-title":"Anaesthesiol Intensive Ther."},{"issue":"3","key":"809_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.5114\/ait.2020.98124","volume":"52","author":"A Markle","year":"2020","unstructured":"Markle A, Horn K, Welter J, Dullenkopf A. An observational study comparing the performance of TOF-Cuff with TOF-Scan monitoring during anaesthetic induction in clinical routine. Anaesthesiol Intensive Ther. 2020;52(3):181\u20136.","journal-title":"Anaesthesiol Intensive Ther."}],"container-title":["European Journal of Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-022-00809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13318-022-00809-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13318-022-00809-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T09:21:41Z","timestamp":1672996901000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s13318-022-00809-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,8]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["809"],"URL":"https:\/\/doi.org\/10.1007\/s13318-022-00809-1","relation":{},"ISSN":["0378-7966","2107-0180"],"issn-type":[{"type":"print","value":"0378-7966"},{"type":"electronic","value":"2107-0180"}],"subject":[],"published":{"date-parts":[[2022,12,8]]},"assertion":[{"value":"15 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Support was provided solely from institutional and\/or departmental sources.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. The study was approved by the Bioethics Committee of the Poznan University of Medical Sciences (No 161\/17).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Written informed consent was obtained from the parents.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Data is provided as electronic supplementary material","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of Data and Material"}},{"value":"The NONMEM code is in the Supplementary Material 2. The Matlab codes used to generate the graphics can be obtained from the corresponding author on reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Participated in clinical study design and study conduct: M.G., A.B., M.M., J.G., K.J., J.R.K., E.G., and A.B.S. Clinical data interpretation: M.G., A.B., and A.B.S. Data curation: J.B. Performed drug concentration measurements: M.K. Performed data analysis and modeling: P.W. All authors contributed to the writing of the manuscript and approved the final version for publication.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contributions"}}]}}